Thus, Kobayashi and co-workers (2005) measured the plasma VEGF levels of pancreatic cancer patients to assess its usefulness as a tumor marker for distinguishing pancreatic carcinoma from chronic pancreatitis [37]. This evidence concerns the gene VEGFA and familial pancreatic carcinoma.